GlobeNewswire Inc | Sep 9, 2020 08:00AM EDT

September 09, 2020

RICHMOND, Calif., Sept. 09, 2020 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO), an industry leader in exoskeleton technology for medical and industrial use, today announced that Jack Glenn, Chief Financial Officer of Ekso Bionics, will present at the H.C. Wainwright 22nd Annual Global Investment Virtual Conference at 11:30 am ET / 8:30 am PT on Wednesday, September 16, 2020.

A live and archived webcast of the presentation will be available on the investor section of the companys website at:www.eksobionics.com.

About Ekso BionicsEkso Bionicsis a leading developer of exoskeleton solutions that amplify human potential by supporting or enhancing strength, endurance and mobility across medical and industrial applications. Founded in 2005, the Company continues to build upon its industry-leading expertise to design some of the most cutting-edge, innovative wearable robots available on the market. Ekso Bionics is the only exoskeleton company to offer technologies that range from helping those with paralysis to stand up and walk, to enhancing human capabilities on job sites across the globe. The Company is headquartered in the San Francisco Bay Area and is listed on the Nasdaq Capital Market under the symbol EKSO. For more information, visit:www.eksobionics.comor follow @EksoBionics on Twitter.

Media Contact: Carrie Yamond Mas 917-371-2320cmas@eksobionics.com

Investor Contact: David Carey 212-867-1768investors@eksobionics.com